col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


41 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Expert Review of Clinical Immunology
  original article Date Title Authors   All Authors
1 [GO] 2025―May―15 Association between inactivated COVID-19 vaccine and semen quality among males recovered from omicron infection: a retrospective cohort study Yunlong Li, Yinxia Su, Yangchang Zhang, Zihao Guo, Zhaoyun Chen, Hui Li, et al. (+10)
2 [GO] 2024―Aug―13 Recent insights into the impacts of COVID-19 on pediatric asthma Carolina da Silva Alves, Raquel Baptista Pestana, Mário Morais-Almeida
3 [GO] 2024―Jul―12 Changes in health-related quality of life in common variable immunodeficiency: an eight-year journey, including the COVID-19 pandemic Federica Pulvirenti, Annalisa Villa, Matteo D’Ambrosi, Gabriella Cusa, Patricia Quijada-Morales, Eduardo de la Fuente-Munoz, et al. (+3)
4 [GO] 2024―Apr―27 How could our genetics impact COVID-19 vaccine response? Keyi Zheng, Amanda Y. Chong, Alexander J. Mentzer
5 [GO] 2023―Dec―15 Managing acute COVID-19 in immunocompromised pediatric patients Federico Mercolini, Nicoletta Abram, Simone Cesaro
6 [GO] 2023―Sep―23 Will SARS-CoV-2 impact the incidence and nature of other respiratory infections? Ahmad Z. Al Meslamani
7 [GO] 2023―Aug―08 COVID-19 and chronic rhinosinusitis: management and comorbidity - what have we learned? L. Klimek, J. Hagemann, T. Huppertz, F. Bärhold, T. Albrecht, F. Klimek, et al. (+4)
8 [GO] 2023―Jun―24 Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic Aarti Pandya, Sonya Parashar, Morgan Waller, Jay Portnoy
9 [GO] 2023―May―16 An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19 Mario C. Deng
10 [GO] 2023―Mar―08 Examining the associations between COVID-19 infection and pediatric type 1 diabetes Bruno Bombaci, Stefano Passanisi, Lacrima Sorrenti, Giuseppina Salzano, Fortunato Lombardo
11 [GO] 2023―Jan―09 Temporal trends in anaphylaxis ED visits over the last decade and the effect of COVID-19 pandemic on these trends Adnan Al Ali, Sofianne Gabrielli, Luca Delli Colli, Marina Delli Colli, Christine McCusker, Ann E Clarke, et al. (+17)
12 [GO] 2022―Sep―01 A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality Angelo Zinellu, Arduino A Mangoni
13 [GO] 2022―Jul―22 Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics Tameena Wais, Mehde Hasan, Vikrant Rai, Devendra K. Agrawal
14 [GO] 2022―May―05 Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2 Rohan Ameratunga, See-Tarn Woon, Richard Steele, Klaus Lehnert, Euphemia Leung, Anna E. S. Brooks
15 [GO] 2022―Apr―29 What is the full potential of baricitinib in treating patients with COVID-19? Kathryn Biddle, Jonathan P E White, Nidhi Sofat
16 [GO] 2022―Apr―09 Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patients Chiara Zanetta, Maria A. Rocca, Massimo Filippi
17 [GO] 2022―Mar―24 Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations and muscle amyloid deposits Marinos C. Dalakas
18 [GO] 2022―Feb―19 The (apparent) antibody paradox in COVID-19 Rohan Ameratunga, See-Tarn Woon, Edward Lea, Richard Steele, Klaus Lehnert, Euphemia Leung, Anna E. S. Brooks
19 [GO] 2021―Dec―29 Evaluating the role of chemokines and chemokine receptors involved in coronavirus infection Gema Olivarria, Thomas E. Lane
20 [GO] 2021―Sep―22 Letter to the editor regarding ‘perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection’ Sudeb C. Dalai, Lance Baldo
21 [GO] 2021―Sep―17 Response to Letter to the Editor: The Clinical Utility of Diagnostic T cell Assays for COVID-19 Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, Hilary Longhurst, Euphemia Leung, Richard Steele, et al. (+3)
22 [GO] 2021―May―21 SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives Rosaria M Ruggeri, Alfredo Campennì, Desiree Deandreis, Massimiliano Siracusa, Renato Tozzoli, Petra Petranović Ovčariček, Luca Giovanella
23 [GO] 2021―Apr―20 The role of IL-6 and IL-6 blockade in COVID-19 Nicola Potere, Alberto Batticciotto, Alessandra Vecchié, Ettore Porreca, Antonella Cappelli, Antonio Abbate, et al. (+2)
24 [GO] 2021―Apr―19 Can we safely use systemic treatment in atopic dermatitis during the COVID-19 pandemic? Overview of selected conventional and biologic systemic therapies Monika Marko, Rafał Pawliczak
25 [GO] 2021―Apr―07 Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis Soheila Rezaei, Behzad Fatemi, Zahra Karimi Majd, Hossein Minaei, Mohammad Peikanpour, Nassim Anjidani, et al. (+3)
26 [GO] 2021―Apr―01 Perspective: The nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection Rohan Ameratunga, See-Tarn Woon, Richard Steele, Russell Snell, Natalie Medlicott, Emily Mears, et al. (+7)
27 [GO] 2021―Mar―31 A comparative review of immunoassays for COVID-19 detection Elham Mohit, Zahra Rostami, Hossein Vahidi
28 [GO] 2021―Mar―31 Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic Ennio Giulio Favalli, Gabriella Maioli, Martina Biggioggero, Roberto Caporali
29 [GO] 2021―Mar―22 Circulating Calprotectin as a Biomarker of COVID-19 Severity Michael Mahler, Pier-Luigi Meroni, Maria Infantino, Katherine A. Buhler, Marvin J. Fritzler
30 [GO] 2021―Mar―22 Perspective: Diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, Hilary Longhurst, Euphemia Leung, Richard Steele, et al. (+3)
31 [GO] 2021―Feb―23 Convalescent Plasma and Hyperimmune Globulin Therapy in COVID-19 Deniz Cagdas
32 [GO] 2021―Feb―05 Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection. Paolo Maggi, Elena Ricci, Vincenzo Messina, Angela Salzillo, Filomena Simeone, Angelo Iodice, Giuseppe Vittorio De Socio
33 [GO] 2021―Jan―08 Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic Isabella Quinti, Ivano Mezzaroma, Cinzia Milito
34 [GO] 2020―Dec―24 Natural history of COVID-19 and therapeutic options Philippe Gautret, Matthieu Million, Pierre-André Jarrot, Laurence Camoin-Jau, Philippe Colson, Florence Fenollar, et al. (+12)
35 [GO] 2020―Nov―05 The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection Onorina Berardicurti, Alessandro Conforti, Piero Ruscitti, Paola Cipriani, Roberto Giacomelli
36 [GO] 2020―Nov―04 Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation Isabelle Amigues, Alexander H Pearlman, Aarat Patel, Pankti Reid, Philip C. Robinson, Rashmi Sinha, et al. (+4)
37 [GO] 2020―Sep―09 Systematic review of the antiviral properties of TRIM56: a potential therapeutic intervention for COVID-19 Fatemeh Heidary, Reza Gharebaghi
38 [GO] 2020―Jul―29 Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia A Manfredi, F Luppi, G Cassone, C Vacchi, C Salvarani, M Sebastiani
39 [GO] 2020―Jul―04 Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19 Sebastian E. Sattui, Jean W. Liew, Elizabeth R. Graef, Ariella Coler-Reilly, Francis Berenbaum, Alí Duarte-García, et al. (+11)
40 [GO] 2020―Jul―02 Expert Opinion on the Management and Follow-up of Uveitis Patients during SARS-CoV-2 Outbreak Dinu Stanescu-Segall, Thomas Sales de Gauzy, Rhianon Reynolds, Livia Faes, Dominika Pohlmann, Kaivon Pakzad-Vaezi, et al. (+7)
41 [GO] 2020―Apr―02 Immune-epidemiological parameters of the novel coronavirus - a perspective Amene Saghazadeh, Nima Rezaei
 [1] 

41 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec